<DOC>
	<DOCNO>NCT00312676</DOCNO>
	<brief_summary>The hypothesis characteristic extend release Depakote allow overnight conversion immediate release extend release form Depakote . This test successfully young patient individual age 60 . We include individual 60 80 year old .</brief_summary>
	<brief_title>Compare Tolerability Overnight Switch Gradual Switch Between Two Different Forms Depakote</brief_title>
	<detailed_description>Twenty patient randomily assign convert overnight ( 10 pt ) six day ( 10 pt ) . Side effect formally evaluate UKU side effect rating scal do 7 day conversion ( day -7 ) , day conversion ( day 0 ) start day +2 , +7 +14 . This investigator conduct evaluation blind conversion status patient . Secondary measure obtain Quality Life measure ( QOLIE-89 ) Day 0 +14 . Plasma sample obtain Day 0 +14 dose total free valproic blood level .</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Problem Behavior</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<criteria>60 yo old stable dose valproate ( Depakote DR ) Unstable neurolgical , medical psychiatric disorder</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2006</verification_date>
	<keyword>Tolerability</keyword>
	<keyword>Depakote DR</keyword>
	<keyword>Depakote ER</keyword>
	<keyword>Elderly</keyword>
	<keyword>Conversion</keyword>
</DOC>